Request

‘Please could you let me know how many Covid-VITT patients have received compensation from the VDPS? I have heard of at least one’

Response

As of 11 August 2022, five claimants with vaccine-induced immune thrombocytopenia and thrombosis (VITT) have been notified their claim has been approved to receive a Vaccine Damage Payment.

Please note that the Vaccine Damage Payment Scheme (VDPS) is not a compensation scheme. It provides a one-off tax-free payment, currently £120,000, to successful applicants who, on very rare occasions, are severely disabled as a result of vaccination against a specified disease, within the meaning of the Vaccine Damage Payments Act. It does not prejudice the right of the disabled person to pursue a claim for damages through the courts.

If you have any queries regarding the data provided, or if you plan on publishing the data, please contact nhsbsa.foirequests@nhs.net ensuring you quote the above reference. This is important to ensure that the figures are not misunderstood or misrepresented.

If you plan on producing a press or broadcast story based upon the data, please contact nhsbsa.communicationsteam@nhs.net. This is important to ensure that the figures are not misunderstood or misrepresented.

The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988 and is subject to NHSBSA copyright. This information is licenced under the terms of the Open Government Licence detailed at: http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Should you wish to re-use the information you must include the following statement: “VDPS, NHSBSA Copyright 2022” This information is licenced under the terms of the Open Government Licence:

http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Failure to do so is a breach of the terms of the licence.

Information you receive which is not subject to NHSBSA Copyright continues to be protected by the copyright of the person, or organisation, from which the information originated. Please obtain their permission before reproducing any third party (non NHSBSA Copyright) information.